Skip to main content
Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
4.100
+0.200 (5.13%)
Mar 9, 2026, 3:54 PM EDT - Market open

Voyager Therapeutics Revenue

Voyager Therapeutics had revenue of $13.37M in the quarter ending September 30, 2025, a decrease of -45.73%. This brings the company's revenue in the last twelve months to $31.32M, down -80.88% year-over-year. In the year 2024, Voyager Therapeutics had annual revenue of $80.00M, down -68.00%.

Revenue (ttm)
$31.32M
Revenue Growth
-80.88%
P/S Ratio
6.92
Revenue / Employee
$182,070
Employees
172
Market Cap
227.96M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202480.00M-170.01M-68.00%
Dec 31, 2023250.01M209.10M511.16%
Dec 31, 202240.91M3.49M9.33%
Dec 31, 202137.42M-133.71M-78.14%
Dec 31, 2020171.13M66.74M63.93%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Keros Therapeutics 244.06M
Protalix BioTherapeutics 61.84M
Alector 21.05M
Sol-Gel Technologies 18.97M
MediWound 16.96M
Cibus 3.79M
Camp4 Therapeutics 3.50M
Humacyte 1.57M
Revenue Rankings

VYGR News

More News